Archive | Bachem AG

Home / Archive

Bachem webinar on reducing solvent consumption with PEC Peptide Easy Clean

Bachem webinar on reducing solvent consumption with PEC Peptide Easy Clean

Tuesday 30th August 2022

By Bachem AG Learn More >

Bachem’s journey to Industry 4.0 manufacturing

Bachem’s journey to Industry 4.0 manufacturing

Thursday 4th August 2022

By Bachem AG Learn More >

51914Expanding into Oligos – Interview

Expanding into Oligos – Interview

Wednesday 27th July 2022

By Bachem AG Learn More >

Bachem’s transformational oligonucleotide manufacturing innovations

Bachem’s transformational oligonucleotide manufacturing innovations

Thursday 14th July 2022

By Bachem AG Learn More >

Bachem – Partner from Research to Marketed API

Thursday 30th June 2022

By Bachem AG Learn More >

Bachem bringing advanced development and manufacturing offers to DDF 2022, Berlin

Bachem bringing advanced development and manufacturing offers to DDF 2022, Berlin

Friday 17th June 2022

By Bachem AG Learn More >

Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances

Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances

Wednesday 15th June 2022

By Bachem AG Learn More >

Bachem to present oligo purification advances at IOPC Milan

Bachem to present oligo purification advances at IOPC Milan

Monday 13th June 2022

By Bachem AG Learn More >

Bachem webinar on reducing risk of nitrosamine contamination of SPPS-produced peptide APIs

Bachem webinar on reducing risk of nitrosamine contamination of SPPS-produced peptide APIs

Friday 10th June 2022

By Bachem AG Learn More >

Bachem – Oligo Therapeutics – Innovation that Transforms Lives

Tuesday 7th June 2022

By Bachem AG Learn More >

Bachem showcasing Custom Synthesis offerings at Franco-Belgian GFPP22 meeting

Bachem showcasing Custom Synthesis offerings at Franco-Belgian GFPP22 meeting

Wednesday 1st June 2022

By Bachem AG Learn More >

Bachem expands large-scale oligonucleotide manufacturing capabilities

Bachem expands large-scale oligonucleotide manufacturing capabilities

Wednesday 25th May 2022

By Bachem AG Learn More >